96 related articles for article (PubMed ID: 2867151)
1. Induction of drug metabolizing enzymes in the liver of rats infested with Fasciola hepatica.
Galtier P; Larrieu G; Lesca P
J Pharm Pharmacol; 1985 Oct; 37(10):751-4. PubMed ID: 2867151
[TBL] [Abstract][Full Text] [Related]
2. Decrease of the in vitro drug-metabolizing activity of the hepatic mixed function oxidase system in rats infected experimentally with Fasciola hepatica: pharmacological implications.
Maffei Facino R; Carini M; Bertuletti R; Genchi C; Malchiodi A
Pharmacol Res Commun; 1981 Sep; 13(8):731-42. PubMed ID: 6794045
[No Abstract] [Full Text] [Related]
3. Incidence of experimental fascioliasis on the activity of drug-metabolizing enzymes in lamb liver.
Galtier P; Larrieu G; Tufenkji AE; Franc M
Drug Metab Dispos; 1986; 14(1):137-41. PubMed ID: 2868858
[TBL] [Abstract][Full Text] [Related]
4. Impairment of drug metabolism by the liver in experimental fascioliasis in the rat.
Galtier P; Battaglia A; More J; Franc M
J Pharm Pharmacol; 1983 Nov; 35(11):729-33. PubMed ID: 6139454
[TBL] [Abstract][Full Text] [Related]
5. Fasciola hepatica: liver enzymes in rats and interaction with chemical inducers.
Galtier P; Eeckhoutte C; Larrieu G
Exp Parasitol; 1987 Apr; 63(2):189-94. PubMed ID: 3569474
[TBL] [Abstract][Full Text] [Related]
6. Antihepatotoxic properties of uridine-diphosphoglucose in liver fluke infection. Experimental fascioliasis in the rat.
Maffei Facino R; Carini M; Genchi C; Tofanetti O; Casciarri I; Bedoschi D
Arzneimittelforschung; 1990 Apr; 40(4):490-8. PubMed ID: 2113387
[TBL] [Abstract][Full Text] [Related]
7. Induction of hepatic drug metabolizing enzymes by coal fly ash in rats.
Srivastava PK; Singh Y; Tyagi SR; Misra UK
Environ Res; 1987 Dec; 44(2):228-37. PubMed ID: 3121300
[TBL] [Abstract][Full Text] [Related]
8. Comparison of hepatic and extrahepatic drug-metabolizing enzyme activities in rats given single or multiple challenge infections with Fasciola hepatica.
Biro-Sauveur B; Eeckhoutte C; Baeza E; Boulard C; Galtier P
Int J Parasitol; 1995 Oct; 25(10):1193-200. PubMed ID: 8557466
[TBL] [Abstract][Full Text] [Related]
9. Induction of microsomal drug metabolizing enzymes by phenobarbitone in the rats exposed to increased environmental temperature.
Pachecka J; Kobylińska K; Zasłona H; Zagdańska B; Bicz W
Acta Pol Pharm; 1991; 48(3-4):35-7. PubMed ID: 1669542
[TBL] [Abstract][Full Text] [Related]
10. Effects of muroctasin on the activities of drug metabolizing enzymes in liver microsomes of rats.
Kamataki T; Komori M; Iwasaki M; Ohi H; Kitada M; Miura T; Ono K
Arzneimittelforschung; 1988 Jul; 38(7A):1019-22. PubMed ID: 3263867
[TBL] [Abstract][Full Text] [Related]
11. Fasciola hepatica: liver microsomal membrane functions in host rat.
Galtier P; Cambon-Gros C; Fernandez Y; Deltour P; Eeckhoutte C; Hoellinger H
Exp Parasitol; 1994 Mar; 78(2):175-82. PubMed ID: 7907029
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of inducers of cytochrome P450 on Mongolian gerbil and rat hepatic microsomal monooxygenase activities.
Fentem JH; Fry JR
Xenobiotica; 1991 Jul; 21(7):895-904. PubMed ID: 1776265
[TBL] [Abstract][Full Text] [Related]
13. Ascorbic acid requirement for the induction of microsomal drug-metabolizing enzymes in a rat mutant unable to synthesize ascorbic acid.
Horio F; Ozaki K; Kohmura M; Yoshida A; Makino S; Hayashi Y
J Nutr; 1986 Nov; 116(11):2278-89. PubMed ID: 3098936
[TBL] [Abstract][Full Text] [Related]
14. Comparison of hepatic and renal drug-metabolising enzyme activities in sheep given single or two-fold challenge infections with Fasciola hepatica.
Calléja C; Bigot K; Eeckhoutte C; Sibille P; Boulard C; Galtier P
Int J Parasitol; 2000 Jul; 30(8):953-8. PubMed ID: 10927086
[TBL] [Abstract][Full Text] [Related]
15. The effects of fascioliasis on the activities of some drug-metabolizing enzymes in desert sheep liver.
Elsheikh HA; Ali BH; Homeida AM; Lutfi AA; Hapke HJ
Br Vet J; 1992; 148(3):249-57. PubMed ID: 1617399
[TBL] [Abstract][Full Text] [Related]
16. Mixed-function oxidase system induction and propylene hepatotoxicity.
Osimitz TG; Conolly RB
J Toxicol Environ Health; 1985; 15(1):39-49. PubMed ID: 2984438
[TBL] [Abstract][Full Text] [Related]
17. Differences in the duration of the enhancement of liver mixed-function oxidase activities in ethanol-fed rats after withdrawal.
Hétu C; Joly JG
Biochem Pharmacol; 1985 Apr; 34(8):1211-6. PubMed ID: 3873242
[TBL] [Abstract][Full Text] [Related]
18. Effects of phenobarbitone and beta-naphthoflavone on hepatic microsomal drug metabolising enzymes of the male beagle dog.
McKillop D
Biochem Pharmacol; 1985 Sep; 34(17):3137-42. PubMed ID: 3929785
[TBL] [Abstract][Full Text] [Related]
19. Induction of hepatic microsomal drug metabolizing enzyme system by levamisole in male mice.
Dalvi RR; Terse PS
J Pharm Pharmacol; 1990 Jan; 42(1):58-9. PubMed ID: 1969953
[TBL] [Abstract][Full Text] [Related]
20. Loss of substrate binding capacity of the hepatic microsomal cytochrome P-450 in Fasciola hepatica infected rats: toxicological implications.
Maffei Facino R; Carini M
Farmaco Sci; 1982 Mar; 37(3):184-91. PubMed ID: 6802668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
